Effect of hypotensive drugs on the circadian blood pressure pattern in essential hypertension: A comparative study

Cardiovascular Drugs and Therapy

Volumn 11, Issue 6, 1997, Pages 795-799

  Zakopoulos, Nikolaos ^a,b   Stamatelopoulos, Stamatios ^a   Moulopoulos, Spyridon ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

Blood pressure monitoring; Blood pressure variability

Indexed keywords

AMILORIDE; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; NIFEDIPINE; PERINDOPRIL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMILORIDE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CIRCADIAN RHYTHM; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INDOLES; MALE; MIDDLE AGED; NIFEDIPINE; PERINDOPRIL; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0031455490     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007774410086     Document Type: Article

References (14)

1. Hansson L. Current and future strategies in the treatment of hypertesion. Am J Cardiol 1988;61:2C-7C.
2. Dzau VJ. Mechanism of the interaction of hypertension and hypercholesterolemia in atherogenesis: The effects of antihypertensive agents. Am Heart J 1988;116:1725-1728.
3. Dipette DJ, Frohlich ED. Cardiac involvement in hypertension. Am J Cardiol 1988;61:67H-72H.
4. Frohlich ED. Hypertension. In: Conn HF, ed. Current Therapy. 1988.
5. Moser M. Relative efficacy of, and some adverse reactions to, different antihypertensive regiments. Am J Cardiol 1989;63:2B-7B.
6. Kelemen MH, Effron MB, Valenti SA, Stewart KJ. Exercise training combined with antihypertensive drug therapy. JAMA 1990;263:2766-2771.
7. Mancini GBJ. Hypertension, hypertrophy and the coronary circulation. Circulation 1991;83:1101-1103.
8. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
9. Conway J, Coats A, Radaelli A. Ambulatory blood pressure in relation to drug treatment and clinical trials. J Hypertens 1990;8(Suppl 6):S83-S85.
10. Gifford RW, Kaplan NM. Thiazides and hypertension in the elderly. Hypertension 1995;25:1052.
11. Kaplan NM. Diuretics: Cornerstone of antihypertensive therapy. Am J Cardiol 1996;77:38-58.
12. Neal WW. Reducing cost and improving compliance. Am J Cardiol 1989;63:17B-20B.
13. Dunn FG, Ventura HO, Messerli FH, Kobrin I, Frohlich ED. Time course of regression of left ventricular hypertrophy in hypertensive patients treated with Atenolol. Circulation 1987;76:254-258.
14. Neutel JM, Schnaper H, Cheung DG, Graettinger WF, Weber MA. Antihypertensive effects of ςblockers administered once daily: 24-hour measurements. Am Heart J 1990;120: 166-171